Locus-specific HERV expression identifies an aggressive, NK-depleted, checkpoint-refractory acral melanoma phenotype

• by Jez L. Marston, Tongyi Fei, Helena Reyes-Gopar, Matthew L. Bendall, Douglas F. Nixon

• July 6, 2026

Clinical evaluation of large language model recommendations in melanoma: comparison with multidisciplinary tumor board decisions in a real-world cohort

• by Belma Babic, Sefika Umihanic, Hedim Osmanovic, Nejra Selak, Erna Sehic-Kozica, Lejla Moranjkic, Inga Marijanovic, Marija Karaga, Amina Jalovcic Suljevic, Sekib Umihanic, Fadil Umihanic, Arzumana Ozegovic-Orucevic

• June 29, 2026

Study explores adding a low-dose, daily oral chemotherapy for patients with melanoma

UCI Health medical oncologist Poorva Vaidya, MD is currently offering a new clinical trial sponsored by the UC Irvine Anti-Cancer Challenge, and lead by Warren Chow, MD, aimed at tackling a persistent challenge in melanoma care if patients fail first-line immunotherapy.

• June 24, 2026

• 1 min

Artificial intelligence in three-dimensional total-body photography for skin cancer surveillance

• by Kai Liang Lew, Kok Swee Sim, Wai Ti Chan

• July 6, 2026